Disparities in Management Patterns and Outcomes of Patients With Non–ST-Elevation Acute Coronary Syndrome With and Without a History of Cerebrovascular Disease - 05/08/11
, Raymond T. Yan, MD a, b, Francois R. Grondin, MD c, Robert C. Welsh, MD d, Barry Rose, MD e, Gabor Gyenes, MD f, Rodney H. Zimmerman, MD g, Real Brossoit, MD h, Gustavo Saposnik, MD i, John J. Graham, MD a, Andrew T. Yan, MD a, b, ⁎ Canadian Acute Coronary Syndromes I and II, Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Acute Coronary Events (CANRACE) Investigators
Corresponding author: Tel: (416) 864-5465; fax: (416) 864-5159Résumé |
Cerebrovascular (CVD) disease is commonly associated with coronary artery disease and adversely affects outcome. The goal of the present study was to examine the temporal management patterns and outcomes in relation to previous CVD in a contemporary “real-world” spectrum of patients with acute coronary syndrome (ACS). From 1999 to 2008, 14,070 patients with non–ST-segment elevation ACS were recruited into the Canadian Acute Coronary Syndrome I (ACS I), ACS II, Global Registry of Acute Coronary Events (GRACE/GRACE2), and Canadian Registry of Acute Coronary Events (CANRACE) prospective multicenter registries. We stratified the study patients according to a history of CVD and compared their treatment and outcomes. Patients with a history of CVD were older, more likely to have pre-existing coronary artery disease, elevated creatinine, higher Killip class, and ST-segment deviation on admission. Despite presenting with greater GRACE risk scores (137 vs 117, p <0.001), patients with previous CVD were less likely to receive evidence-based antiplatelet and antithrombin therapies during the initial 24 hours of hospital admission. They were also less likely to undergo in-hospital coronary angiography and revascularization. These disparities in medical and invasive management were preserved temporally across all 4 registries. Patients with concomitant CVD had worse in-hospital outcomes. Previous CVD remained an independent predictor of in-hospital mortality (adjusted odds ratio 1.43, 95% confidence interval 1.06 to 1.92, p = 0.019) after adjusting for other powerful prognosticators in the GRACE risk score. However, it was independently associated with a lower use of in-hospital coronary angiography (adjusted odds ratio 0.70, 95% confidence interval 0.60 to 0.83, p <0.001). Underestimation of patient risk was the most common reason for not pursuing an invasive strategy. Revascularization was independently associated with lower 1-year mortality (adjusted odds ratio 0.48, 95% confidence interval 0.33 to 0.71, p <0.001), irrespective of a history of CVD. In conclusion, for patients presenting with non–ST-segment elevation-ACS, a history of CVD was independently associated with worse outcomes, which might have been, in part, because of the underuse of evidence-based medical and invasive therapies.
Le texte complet de cet article est disponible en PDF.Plan
| Dr. Yan was supported by a New Investigator Award from the Heart and Stroke Foundation of Canada, Ottawa, Ontario, Canada. The Canadian ACS registries were sponsored by the Canadian Heart Research Centre, Toronto, Ontario, Canada (a federally incorporated not-for-profit academic research organization) and Key Pharmaceuticals, Division of Schering Canada, Inc., Mississauga, Ontario, Canada. GRACE and CANRACE were sponsored by an unrestricted grant from Sanofi-Aventis Canada Inc., Laval, Quebec, Canada and Bristol-Myers Squibb Canada, Montreal, Quebec, Canada. |
|
| The industrial sponsors had no involvement in the study conception or design; collection, analysis, and interpretation of data; writing, review, or approval of the report; or the decision to submit the report for publication. |
Vol 105 - N° 8
P. 1083-1089 - avril 2010 Retour au numéro
Article précédent
- Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft Intervention
- Michael S. Lee, Tae Yang, David E. Kandzari, Jonathan M. Tobis, Hsini Liao, Ehtisham Mahmud
- Importance of Measuring Glycosylated Hemoglobin in Patients With Myocardial Infarction and Known Diabetes Mellitus
- Joshua M. Stolker, Dazhong Sun, Darcy G. Conaway, Philip G. Jones, Frederick A. Masoudi, Pamela N. Peterson, Harlan M. Krumholz, Mikhail Kosiborod, John A. Spertus
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?